Optimizing Models of Non-Coding Genetic Risk in Age-Related Macular Degeneration
年龄相关性黄斑变性非编码遗传风险模型的优化
基本信息
- 批准号:10574620
- 负责人:
- 金额:$ 49.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:10q26AddressAffectAgeAge related macular degenerationAutomobile DrivingBiological ModelsBiologyBlindnessCell Culture SystemCell physiologyCellsDNA SequenceDataDevelopmentDiseaseElementsEnhancersEvolutionExperimental ModelsGene ExpressionGenesGeneticGenetic RiskGenetic VariationGenetic studyGoalsHistologyHumanIn VitroInheritedKnock-outKnockout MiceKnowledgeLate-Onset DisorderMapsMethodsMicroRNAsModelingMusMutationOrganoidsOther GeneticsOutcomePersonsPublic HealthRegulationRegulatory ElementResearchRetinaRetinal DiseasesRiskRisk FactorsRoleShapesStructureStructure of retinal pigment epitheliumStudy modelsSystemTestingTissuesTransgenic MiceUnited StatesUntranslated RNAVisionVision DisordersVisualWorkbarrier to testingcell typeexperimental studygenetic analysisgenetic risk factorgenome wide association studyimprovedin vitro Modelin vitro testingin vivoinduced pluripotent stem cellinsightmaculamodel organismmouse genomemouse modelmultiple omicsmyocyte-specific enhancer-binding-factor 2Cnovelrisk variantsingle-cell RNA sequencingtherapy developmenttissue culture
项目摘要
PROJECT SUMMARY/ABSTRACT
Genome-wide association studies (GWAS) and other genetic analyses consistently implicate non-coding cis-
regulatory elements (CREs) in age-related macular degeneration (AMD). However, the contribution of CREs to
the risk of developing AMD remains poorly understood because the function these elements has not yet been
directly tested. The barrier for testing AMD-associated CREs is in part due to the challenge of developing
experimentally validated model systems. CREs can be cell-type-specific and are not necessarily conserved
between humans and model organisms. It therefore remains unclear which CREs may be studied in vivo in
transgenic mice versus which require an in vitro human cell system. This gap in knowledge is a significant
obstacle toward understanding the genetic regulation of normal human vision and to understanding the
contribution of specific CREs to AMD. The long-term goal for our research is to understand how genetic variation
within CREs shapes the structure and function of the retina and contributes to the risk of developing AMD and
other disorders of vision. The focused objective of this proposal is to optimize and validate model systems for
studying the function of AMD-associated CREs. The central hypothesis driving this work is that some AMD-
associated CREs will be conserved between humans and mice due to their functional importance in vision. Other
CREs may be human-specific due to their essential roles in the macula, a part of the retina that is not present in
mice. In each of these cases, one or more optimal systems will be required to understand the function of each
AMD-associated CRE. To test this hypothesis, we are pursuing the following specific aims: 1) Determine the
functional conservation of AMD-associated CREs between humans and mice. 2) Test the function of a specific
CRE that is known to be conserved between humans and mice from our preliminary studies in a newly developed
mouse knockout model. 3) Test the requirement of human-specific CREs that are among the leading contributors
to AMD risk, in induced human retinal tissue cultures. Together these experiments will enable discovery of
genetic contributions to human vision and inherited visual diseases that have thus far been inaccessible using
current methods.
项目总结/摘要
全基因组关联研究(GWAS)和其他遗传分析一致表明非编码顺式-
调节元件(克雷斯)在老年性黄斑变性(AMD)中的作用。然而,克雷斯对
发展为AMD的风险仍然知之甚少,因为这些元素的功能尚未被
直接测试。测试AMD相关克雷斯的障碍部分是由于开发
实验验证的模型系统。克雷斯可以是细胞类型特异性的,并且不一定是保守的
人类和模式生物之间的关系因此,尚不清楚哪些克雷斯可以在体内进行研究,
转基因小鼠相对于需要体外人细胞系统的转基因小鼠。这种知识上的差距是一个重大的问题。
这是理解正常人类视觉的遗传调节和理解
特定克雷斯对AMD的贡献。我们研究的长期目标是了解遗传变异是如何
在克雷斯内形成视网膜的结构和功能,并有助于发展AMD的风险,
其他视力障碍。本提案的重点目标是优化和验证模型系统,
研究AMD相关克雷斯的功能。推动这项工作的中心假设是,一些AMD-
由于其在视觉中的功能重要性,相关的克雷斯在人和小鼠之间是保守的。其他
克雷斯可能是人类特异性的,这是由于它们在黄斑中的重要作用,黄斑是视网膜中不存在的一部分。
小鼠在每一种情况下,都需要一个或多个优化系统来理解每个系统的功能。
AMD相关CRE。为了验证这一假设,我们正在追求以下具体目标:1)确定
人类和小鼠之间AMD相关克雷斯的功能保守性。2)测试特定的功能
CRE是已知的是保守的人类和小鼠之间从我们的初步研究,在一个新开发的
小鼠基因敲除模型。3)测试主要贡献者之一的人类特异性克雷斯的要求
AMD的风险,在诱导人类视网膜组织培养。这些实验将共同发现
遗传对人类视力的贡献和遗传性视力疾病,迄今为止,
目前的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIMOTHY JOEL CHERRY其他文献
TIMOTHY JOEL CHERRY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIMOTHY JOEL CHERRY', 18)}}的其他基金
Optimizing Models of Non-Coding Genetic Risk in Age-Related Macular Degeneration
年龄相关性黄斑变性非编码遗传风险模型的优化
- 批准号:
10343475 - 财政年份:2022
- 资助金额:
$ 49.23万 - 项目类别:
Non-Coding Genetic Vulnerabilities in Human Photoreceptor Function and Disease
人类感光功能和疾病中的非编码遗传漏洞
- 批准号:
10596515 - 财政年份:2019
- 资助金额:
$ 49.23万 - 项目类别:
Non-Coding Genetic Vulnerabilities in Human Photoreceptor Function and Disease
人类感光功能和疾病中的非编码遗传漏洞
- 批准号:
9902484 - 财政年份:2019
- 资助金额:
$ 49.23万 - 项目类别:
Non-Coding Genetic Vulnerabilities in Human Photoreceptor Function and Disease
人类感光功能和疾病中的非编码遗传漏洞
- 批准号:
10372058 - 财政年份:2019
- 资助金额:
$ 49.23万 - 项目类别:
Non-Coding Genetic Vulnerabilities in Human Photoreceptor Function and Disease
人类感光功能和疾病中的非编码遗传漏洞
- 批准号:
10132332 - 财政年份:2019
- 资助金额:
$ 49.23万 - 项目类别:
The role of cortical neuron and circuit function in tau induced neurodegeneration
皮质神经元和回路功能在 tau 诱导的神经变性中的作用
- 批准号:
8097548 - 财政年份:2010
- 资助金额:
$ 49.23万 - 项目类别:
The role of cortical neuron and circuit function in tau induced neurodegeneration
皮质神经元和回路功能在 tau 诱导的神经变性中的作用
- 批准号:
7912300 - 财政年份:2010
- 资助金额:
$ 49.23万 - 项目类别:
The role of cortical neuron and circuit function in tau induced neurodegeneration
皮质神经元和回路功能在 tau 诱导的神经变性中的作用
- 批准号:
8258751 - 财政年份:2010
- 资助金额:
$ 49.23万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 49.23万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 49.23万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 49.23万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 49.23万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 49.23万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 49.23万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 49.23万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 49.23万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 49.23万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 49.23万 - 项目类别:
Research Grant